RMC-9805

RMC-9805 · Revolution Medicines, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RMC-9805, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors [Phase 1]